tradingkey.logo

Transmedics Group Inc

TMDX
135.060USD
+5.460+4.21%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
4.61BCap. mercado
49.90P/E TTM

Transmedics Group Inc

135.060
+5.460+4.21%

Más Datos de Transmedics Group Inc Compañía

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Información de Transmedics Group Inc

Símbolo de cotizaciónTMDX
Nombre de la empresaTransmedics Group Inc
Fecha de salida a bolsaMay 02, 2019
Director ejecutivoHassanein (Waleed H)
Número de empleados728
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 02
Dirección200 Minuteman Road
CiudadANDOVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01810
Teléfono19785520900
Sitio Webhttps://www.transmedics.com/
Símbolo de cotizaciónTMDX
Fecha de salida a bolsaMay 02, 2019
Director ejecutivoHassanein (Waleed H)

Ejecutivos de Transmedics Group Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
481.61K
-47529.00%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
177.21K
+2134.00%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.13K
--
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
7.04K
-5640.00%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
+2134.00%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
+2134.00%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
4.06K
+2134.00%
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
331.00
-15653.00%
Dr. Tamer I. Khayal, M.D.
Dr. Tamer I. Khayal, M.D.
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Edward M. Basile
Mr. Edward M. Basile
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
481.61K
-47529.00%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
177.21K
+2134.00%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
12.13K
--
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
7.04K
-5640.00%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
4.06K
+2134.00%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
4.06K
+2134.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
OCS Liver net revenue
107.94M
75.67%
OCS Heart net revenue
30.59M
21.44%
OCS Lung net revenue
4.11M
2.88%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
139.01M
97.46%
All other countries
3.63M
2.54%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
OCS Liver net revenue
107.94M
75.67%
OCS Heart net revenue
30.59M
21.44%
OCS Lung net revenue
4.11M
2.88%

Estadísticas de accionistas

Actualizado: sáb., 31 de ene
Actualizado: sáb., 31 de ene
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.86%
Fidelity Management & Research Company LLC
13.45%
The Vanguard Group, Inc.
10.53%
State Street Investment Management (US)
3.74%
Two Sigma Investments, LP
3.10%
Otro
55.32%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.86%
Fidelity Management & Research Company LLC
13.45%
The Vanguard Group, Inc.
10.53%
State Street Investment Management (US)
3.74%
Two Sigma Investments, LP
3.10%
Otro
55.32%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
72.28%
Investment Advisor/Hedge Fund
23.64%
Hedge Fund
7.07%
Research Firm
4.62%
Individual Investor
2.95%
Bank and Trust
2.03%
Pension Fund
1.35%
Sovereign Wealth Fund
0.18%
Family Office
0.15%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
800
38.04M
111.30%
-5.53M
2025Q3
762
37.62M
110.09%
-8.17M
2025Q2
746
42.27M
124.01%
-2.30M
2025Q1
751
42.32M
125.08%
-2.32M
2024Q4
728
40.09M
119.11%
-642.74K
2024Q3
673
39.30M
117.10%
+1.37M
2024Q2
615
36.53M
110.85%
-3.27M
2024Q1
544
37.44M
113.97%
-4.28M
2023Q4
512
38.18M
116.94%
-3.46M
2023Q3
482
38.42M
117.77%
-240.92K
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
4.74M
13.86%
+9.44K
+0.20%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.60M
13.45%
-31.07K
-0.67%
Sep 30, 2025
The Vanguard Group, Inc.
3.60M
10.53%
+9.16K
+0.26%
Sep 30, 2025
State Street Investment Management (US)
1.28M
3.74%
-9.47K
-0.73%
Sep 30, 2025
Two Sigma Investments, LP
1.06M
3.1%
+366.05K
+52.85%
Sep 30, 2025
Nomura Investment Management Business Trust
906.27K
2.65%
-45.84K
-4.81%
Sep 30, 2025
Geode Capital Management, L.L.C.
813.57K
2.38%
+8.92K
+1.11%
Sep 30, 2025
Driehaus Capital Management, LLC
738.16K
2.16%
-115.88K
-13.57%
Sep 30, 2025
Hood River Capital Management LLC
678.44K
1.99%
-1.41K
-0.21%
Sep 30, 2025
Emerald Advisers LLC
626.03K
1.83%
-68.95K
-9.92%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Global X HealthTech ETF
4.75%
Clough Select Equity ETF
2.87%
Invesco S&P SmallCap Health Care ETF
2.75%
State Street SPDR S&P Health Care Equipment ETF
2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.47%
iShares S&P Small-Cap 600 Growth ETF
0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.58%
Ver más
Global X HealthTech ETF
Proporción4.75%
Clough Select Equity ETF
Proporción2.87%
Invesco S&P SmallCap Health Care ETF
Proporción2.75%
State Street SPDR S&P Health Care Equipment ETF
Proporción2.18%
Invesco S&P SmallCap 600 Pure Growth ETF
Proporción1.54%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción1.47%
iShares S&P Small-Cap 600 Growth ETF
Proporción0.63%
State Street SPDR S&P 600 Small Cap Growth ETF
Proporción0.61%
First Trust Multi-Manager Small Cap Opportunities ETF
Proporción0.58%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proporción0.58%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI